Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 33088 | 129 | 36.5 | 79% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
| 494 | 3 | AVIAN DISEASES//AVIAN PATHOLOGY//NEWCASTLE DISEASE VIRUS | 22905 |
| 1525 | 2 | ADJUVANT//ISCOM//VACCINE | 7477 |
| 33088 | 1 | VIROSOMES//FUSOGENIC LIPOSOME//FRAGMENT A OF DIPHTHERIA TOXIN | 129 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | VIROSOMES | authKW | 2935881 | 31% | 31% | 40 |
| 2 | FUSOGENIC LIPOSOME | authKW | 1972569 | 12% | 56% | 15 |
| 3 | FRAGMENT A OF DIPHTHERIA TOXIN | authKW | 473420 | 2% | 100% | 2 |
| 4 | IRIVS | authKW | 473420 | 2% | 100% | 2 |
| 5 | INFLUENZA VIROSOMES | authKW | 473416 | 3% | 50% | 4 |
| 6 | HEPATITIS C VACCINE | authKW | 315612 | 2% | 67% | 2 |
| 7 | MOL VIROL SECT | address | 255226 | 13% | 6% | 17 |
| 8 | ACQUISITION OF INFECTIVITY BY TRYPSIN | authKW | 236710 | 1% | 100% | 1 |
| 9 | ADJUVANCE | authKW | 236710 | 1% | 100% | 1 |
| 10 | ARTMENT PHARMACEUT SCI | address | 236710 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Immunology | 515 | 31% | 0% | 40 |
| 2 | Medicine, Research & Experimental | 412 | 22% | 0% | 28 |
| 3 | Pharmacology & Pharmacy | 163 | 22% | 0% | 29 |
| 4 | Biochemistry & Molecular Biology | 74 | 23% | 0% | 30 |
| 5 | Virology | 55 | 5% | 0% | 7 |
| 6 | Biotechnology & Applied Microbiology | 45 | 9% | 0% | 12 |
| 7 | Biophysics | 26 | 6% | 0% | 8 |
| 8 | Oncology | 11 | 7% | 0% | 9 |
| 9 | Biochemical Research Methods | 10 | 4% | 0% | 5 |
| 10 | Chemistry, Medicinal | 8 | 3% | 0% | 4 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | MOL VIROL SECT | 255226 | 13% | 6% | 17 |
| 2 | ARTMENT PHARMACEUT SCI | 236710 | 1% | 100% | 1 |
| 3 | BIOSUR ES GRP | 236710 | 1% | 100% | 1 |
| 4 | CHIRURG FOR SPITAL MANAGEMENT | 236710 | 1% | 100% | 1 |
| 5 | MED ONCOPHARMACOL | 236710 | 1% | 100% | 1 |
| 6 | MOL VIROL SEC | 236710 | 1% | 100% | 1 |
| 7 | OR DYNAM SYST UNIT | 236710 | 1% | 100% | 1 |
| 8 | OSAKA BRANCH FUNDAMENTAL S DEV MED | 236710 | 1% | 100% | 1 |
| 9 | ST BARTHOLOMEWS ROYAL LONDON QUEEN MARY MED | 236710 | 1% | 100% | 1 |
| 10 | G SEGRE PHARMACOL | 118354 | 1% | 50% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | JOURNAL OF LIPOSOME RESEARCH | 14505 | 5% | 1% | 6 |
| 2 | VACCINE | 5250 | 16% | 0% | 20 |
| 3 | EXPERT REVIEW OF VACCINES | 1708 | 2% | 0% | 3 |
| 4 | FUTURE LIPIDOLOGY | 1506 | 1% | 1% | 1 |
| 5 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 601 | 2% | 0% | 3 |
| 6 | ACTA PHARMACEUTICA | 585 | 1% | 0% | 1 |
| 7 | PATHOGENS AND DISEASE | 535 | 1% | 0% | 1 |
| 8 | BIOPHARM INTERNATIONAL | 451 | 1% | 0% | 1 |
| 9 | EXPERT OPINION ON BIOLOGICAL THERAPY | 450 | 2% | 0% | 2 |
| 10 | RESEARCH IN VIROLOGY | 448 | 1% | 0% | 1 |
Author Key Words |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | VIROSOMES | 2935881 | 31% | 31% | 40 | Search VIROSOMES | Search VIROSOMES |
| 2 | FUSOGENIC LIPOSOME | 1972569 | 12% | 56% | 15 | Search FUSOGENIC+LIPOSOME | Search FUSOGENIC+LIPOSOME |
| 3 | FRAGMENT A OF DIPHTHERIA TOXIN | 473420 | 2% | 100% | 2 | Search FRAGMENT+A+OF+DIPHTHERIA+TOXIN | Search FRAGMENT+A+OF+DIPHTHERIA+TOXIN |
| 4 | IRIVS | 473420 | 2% | 100% | 2 | Search IRIVS | Search IRIVS |
| 5 | INFLUENZA VIROSOMES | 473416 | 3% | 50% | 4 | Search INFLUENZA+VIROSOMES | Search INFLUENZA+VIROSOMES |
| 6 | HEPATITIS C VACCINE | 315612 | 2% | 67% | 2 | Search HEPATITIS+C+VACCINE | Search HEPATITIS+C+VACCINE |
| 7 | ACQUISITION OF INFECTIVITY BY TRYPSIN | 236710 | 1% | 100% | 1 | Search ACQUISITION+OF+INFECTIVITY+BY+TRYPSIN | Search ACQUISITION+OF+INFECTIVITY+BY+TRYPSIN |
| 8 | ADJUVANCE | 236710 | 1% | 100% | 1 | Search ADJUVANCE | Search ADJUVANCE |
| 9 | BAND 3 PROTEIN PHAGOCYTIC ACTIVITY | 236710 | 1% | 100% | 1 | Search BAND+3+PROTEIN+PHAGOCYTIC+ACTIVITY | Search BAND+3+PROTEIN+PHAGOCYTIC+ACTIVITY |
| 10 | BETA GLOBIN 5 UNTRANSLATED REGIONS | 236710 | 1% | 100% | 1 | Search BETA+GLOBIN+5+UNTRANSLATED+REGIONS | Search BETA+GLOBIN+5+UNTRANSLATED+REGIONS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | MOSER, C , MULLER, M , KAESER, MD , WEYDEMANN, U , AMACKER, M , (2013) INFLUENZA VIROSOMES AS VACCINE ADJUVANT AND CARRIER SYSTEM.EXPERT REVIEW OF VACCINES. VOL. 12. ISSUE 7. P. 779-791 | 27 | 37% | 21 |
| 2 | CUSI, MG , (2006) APPLICATIONS OF INFLUENZA VIROSOMES AS A DELIVERY SYSTEM.HUMAN VACCINES. VOL. 2. ISSUE 1. P. 1-7 | 27 | 47% | 16 |
| 3 | HOMHUAN, A , (2009) VIROSOME VACCINES AND THEIR APPLICATION IN CANCER IMMUNOTHERAPY.ASIAN BIOMEDICINE. VOL. 3. ISSUE 4. P. 365 -373 | 24 | 48% | 1 |
| 4 | MOSER, C , AMACKER, M , KAMMER, AR , RASI, S , WESTERFELD, N , ZURBRIGGEN, R , (2007) INFLUENZA VIROSOMES AS A COMBINED VACCINE CARRIER AND ADJUVANT SYSTEM FOR PROPHYLACTIC AND THERAPEUTIC IMMUNIZATIONS.EXPERT REVIEW OF VACCINES. VOL. 6. ISSUE 5. P. 711-721 | 27 | 42% | 27 |
| 5 | MOSER, C , AMACKER, M , ZURBRIGGEN, R , (2011) INFLUENZA VIROSOMES AS A VACCINE ADJUVANT AND CARRIER SYSTEM.EXPERT REVIEW OF VACCINES. VOL. 10. ISSUE 4. P. 437-446 | 24 | 29% | 30 |
| 6 | ABDOLI, A , SOLEIMANJAHI, H , KHEIRI, MT , JAMALI, A , MAZAHERI, V , ALITAPPEH, MA , (2014) AN H1-H3 CHIMERIC INFLUENZA VIROSOME CONFERS COMPLETE PROTECTION AGAINST LETHAL CHALLENGE WITH PR8 (H1N1) AND X47 (H3N2) VIRUSES IN MICE.PATHOGENS AND DISEASE. VOL. 72. ISSUE 3. P. 197 -207 | 15 | 38% | 1 |
| 7 | LIU, HQ , TU, ZG , FENG, F , SHI, HF , CHEN, KP , XU, XM , (2015) VIROSOME, A HYBRID VEHICLE FOR EFFICIENT AND SAFE DRUG DELIVERY AND ITS EMERGING APPLICATION IN CANCER TREATMENT.ACTA PHARMACEUTICA. VOL. 65. ISSUE 2. P. 105 -116 | 20 | 25% | 1 |
| 8 | BHATTACHARYA, S , MAZUMDER, B , (2011) VIROSOMES: A NOVEL STRATEGY FOR DRUG DELIVERY AND TARGETING.BIOPHARM INTERNATIONAL. VOL. 24. ISSUE 1. P. S9-+ | 10 | 56% | 0 |
| 9 | DAEMEN, T , DE MARE, A , BUNGENER, L , DE JONGE, J , HUCKRIEDE, A , WILSCHUT, J , (2005) VIROSOMES FOR ANTIGEN AND DNA DELIVERY.ADVANCED DRUG DELIVERY REVIEWS. VOL. 57. ISSUE 3. P. 451-463 | 17 | 33% | 50 |
| 10 | KAMMER, AR , AMACKER, M , RASI, S , WESTERFELD, N , GREMION, C , NEUHAUS, D , ZURBRIGGEN, R , (2007) A NEW AND VERSATILE VIROSOMAL ANTIGEN DELIVERY SYSTEM TO INDUCE CELLULAR AND HUMORAL IMMUNE RESPONSES.VACCINE. VOL. 25. ISSUE 41. P. 7065 -7074 | 9 | 53% | 16 |
Classes with closest relation at Level 1 |